SmartCardia announced today that it received FDA clearance for mobile outpatient cardiac telemetry (OCT/MCT) for its ECG ...

Can AI predict heart disease better than doctors? The new AIRE model uses ECG data to accurately predict mortality and ...

Several companies started designing implantable diagnostic devices for syncope and general cardiac arrhythmia monitoring, [9–12] demonstrating a growing interest about this application not only ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

Pharmacy-Based ECG Screening: Enables convenient and efficient ECG screenings ... Sony's mSafety platform by integrating additional connected digital health monitoring devices, similar to the ...

Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

If there are complexities or greater risks, or labour has been artificially induced, continuous monitoring is recommended.

Technological advancements in noninvasive and minimally invasive methods for hemodynamic monitoring are pivotal drivers. Continuous research and development efforts by industry leaders to understand ...

Cardiac care plans are ideal for individuals with pre-existing heart conditions or a family history of heart issues. Those ...

Symptoms such as heart pain, palpitations and shortness of breath may be transient and can be difficult to record by conventional devices. With the OMRON® Portable ECG Monitor HCG-801 ...